{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:50:04Z","timestamp":1770969004628,"version":"3.50.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00293","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:01:28Z","timestamp":1565326888000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Innovative Therapeutic and Immunomodulatory Strategies for Protozoan Infections"],"prefix":"10.3389","volume":"9","author":[{"given":"Jorge Enrique","family":"G\u00f3mez Mar\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"El Bissati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/trstmh\/trx021","article-title":"Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia","volume":"111","author":"Aponte","year":"2017","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1757913916671160","article-title":"Evolution of Chagas' disease in Brazil. Epidemiological perspective and challenges for the future: a critical review","volume":"137","author":"Bello Corassa","year":"2016","journal-title":"Perspect. Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.imbio.2015.07.009","article-title":"A rational approach to select immunogenic peptides that induce IFN-\u03b3 response against Toxoplasma gondii in human leukocytes","volume":"220","author":"Cardona","year":"2015","journal-title":"Immunobiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/bjo.2008.155861","article-title":"Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral center in Colombia","volume":"93","author":"de la Torre","year":"2009","journal-title":"Br. J. Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e85955","DOI":"10.1172\/jci.insight.85955","article-title":"Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii","volume":"1","author":"El Bissati","year":"2016","journal-title":"JCI Insight"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.vaccine.2014.03.092","article-title":"Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice","volume":"32","author":"El Bissati","year":"2014","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41541-017-0024-6","article-title":"Protein nanovaccine confers robust immunity against Toxoplasma","volume":"2","author":"El Bissati","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1586\/14760584.7.5.597","article-title":"Malaria vaccines: a toy for travelers or a tool for eradication?","volume":"7","author":"Genton","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0169-4758(99)01614-2","article-title":"No NO production during human Toxoplasma infection","volume":"16","author":"G\u00f3mez-Marin","year":"2000","journal-title":"Parasitol. Today"},{"key":"B11","volume-title":"Protozoologia Medica","author":"Gomez-Marin","year":"2010"},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.22354\/IN.V23I2.777","article-title":"Antiparasitic phytotherapy perspectives, scope and current development","volume":"23","author":"Osorio","year":"2019","journal-title":"Infection"},{"key":"B13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.7705\/biomedica.v34i4.2204","article-title":"Transmisi\u00f3n oral de Trypanosoma cruzi: un nuevo escenario epidemiol\u00f3gico de la enfermedad de Chagas en Colombia y otros pa\u00edses suramericanos","volume":"34","author":"Rueda","year":"2014","journal-title":"Biom\u00e9dica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-med-022411-192402","article-title":"Vaccines for malaria: how close are we?","volume":"63","author":"Thera","year":"2012","journal-title":"Annu. Rev. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00430-014-0339-0","article-title":"Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis","volume":"203","author":"Torres-Morales","year":"2014","journal-title":"Med. Microbiol. Immunol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:01:29Z","timestamp":1565326889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":15,"alternative-id":["10.3389\/fcimb.2019.00293"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00293","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"article-number":"293"}}